Updated Jul 16, 2026
Disbrow Joshua R. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Joshua R. Disbrow is the Chief Executive Officer and a Director of Aytu BioPharma, Inc., a specialty pharmaceutical company focused on prescription therapeutics and consumer health products. He has been involved in the pharmaceutical industry, particularly in developing treatments for pediatric conditions.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-27 | ZYXI | ZYNEX INC | D — Derivative transaction | 89.5K | $0.00 | |
| 2026-03-27 | ZYXI | ZYNEX INC | D — Derivative transaction | 12.5K | $0.00 | |
| 2025-10-03 | AYTU | AYTU BIOPHARMA, INC | A — Grant or award | 22.5K | $0.00 | |
| 2025-10-03 | AYTU | AYTU BIOPHARMA, INC | A — Grant or award | 31.4K | $0.00 |
Joshua R. Disbrow is the Chief Executive Officer and a Director of Aytu BioPharma, Inc., a specialty pharmaceutical company focused on prescription therapeutics and consumer health products. He has been involved in the pharmaceutical industry, particularly in developing treatments for pediatric conditions.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Disbrow Joshua R. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.